These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32497749)

  • 21. Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders?
    Palumbo D; Guazzarotti G; De Cobelli F
    J Vasc Interv Radiol; 2020 Sep; 31(9):1494-1496. PubMed ID: 32768277
    [No Abstract]   [Full Text] [Related]  

  • 22. Intra-arterial thrombosis associated with COVID-19.
    Hamilton KV; Hussey KK
    J Vasc Surg; 2020 Aug; 72(2):757-758. PubMed ID: 32425325
    [No Abstract]   [Full Text] [Related]  

  • 23. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
    Thachil J; Longstaff C; Favaloro EJ; Lippi G; Urano T; Kim PY;
    J Thromb Haemost; 2020 Sep; 18(9):2408-2411. PubMed ID: 32881272
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.
    Wang J; Zhang H; Qiao R; Ge Q; Zhang S; Zhao Z; Tian C; Ma Q; Shen N
    J Int Med Res; 2020 Sep; 48(9):300060520955037. PubMed ID: 32960106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
    Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
    J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
    Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
    Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboembolic events and Covid-19.
    Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe COVID-19 infection associated with endothelial activation.
    Escher R; Breakey N; Lämmle B
    Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
    [No Abstract]   [Full Text] [Related]  

  • 33. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 34. D-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019: a meta-analysis.
    Lima WG; Barra A; Brito JCM; Nizer WSC
    Blood Coagul Fibrinolysis; 2020 Jul; 31(5):335-338. PubMed ID: 32618589
    [No Abstract]   [Full Text] [Related]  

  • 35. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.
    Carbone F; Montecucco F; Twickler M
    Eur J Clin Invest; 2020 Jul; 50(7):e13311. PubMed ID: 32511751
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 and thrombosis: Beyond a casual association.
    López Castro J
    Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683
    [No Abstract]   [Full Text] [Related]  

  • 37. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalassemic Child Presenting with Anosmia due to COVID-19.
    Marhaeni W; Wijaya AB; Kusumaningtyas P; Mapianto RS
    Indian J Pediatr; 2020 Sep; 87(9):750. PubMed ID: 32519260
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia.
    Wang F; Wang H; Fan J; Zhang Y; Wang H; Zhao Q
    Gastroenterology; 2020 Jul; 159(1):367-370. PubMed ID: 32247022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.